Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (6.098%)
Market Cap: £12.26m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Statement

30 Jan 2019 07:00

RNS Number : 4661O
Ingenta PLC
30 January 2019
 

The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

30 January 2019

 

Ingenta plc("Ingenta" or the "Group")

Trading Update

Ingenta plc (AIM: ING), a leading software and services provider to the publishing and media industry, provides the following trading update for the year ended 31 December 2018.

The Group is pleased to confirm that it has made considerable progress in its business combination plans, moving away from a divisional product siloed structure, which will enable the Group to operate in a more efficient and nimble manner going forward. The Group expects to report revenue of £12m and adjusted EBITDA of approximately £0.8 million. The Group generated operating cash inflows of £2.3m in the year, before expenditure on research and development of £1.8m, acquisition costs of £0.25m, dividends of £0.25m and the planned reorganisation costs of £0.8m, resulting in net cash balances at year-end of £1.3 million.

During the year, the business took the opportunity to impair its non-core Chinese joint venture investment and goodwill from legacy business combinations by £0.3m and £0.6m respectively, both of which were non-cash transactions.

Progress made by Ingenta's management over the past 18 months to reorganise and reposition the business have resulted in cumulative cost reductions of approximately £4m on an annualised basis. These efforts have substantially de-risked the Company, enabling it to produce increased profitability from a lower revenue base and allowing us to look forward to 2019 with considerable optimism.

The Board confirms its intention to pay a dividend of 1.5 pence per ordinary share for the 2018 financial year and intends to announce its final results for 2018 in March, subject to shareholder approval at the AGM.

Scott Winner, Chief Executive Officer, commented:

"The results of our recent business combination plan are now starting to produce results and I look forward to 2019 with great enthusiasm. The business is now leaner and focussed on delivering first class services to all our customers meaning we are significantly better placed to propel the business through the next stage of its growth".

 

For further information contact:

 

Ingenta PlcScott Winner, Jon Sheffield

+44 (0) 1865 397 800

Cenkos Securities plcNicholas Wells, Harry Hargreaves

+44 (0) 20 7397 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUACGUPBGRB
Date   Source Headline
14th Nov 20195:06 pmRNSTransaction in Own Shares
28th Oct 20197:00 amRNSContract Wins
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSTransaction in Own Shares
10th Oct 20197:00 amRNSShare Buyback Programme
23rd Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSContract Wins
11th Jun 20197:00 amRNSContract Wins
23rd May 201912:45 pmRNSAGM Statement
23rd Apr 20195:23 pmRNSHolding(s) in Company
18th Apr 20192:30 pmRNSDividend Declaration, Posting of AR&A & AGM Notice
2nd Apr 20194:30 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSFinal Results
6th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSDirector/PDMR Shareholding
30th Jan 20197:00 amRNSTrading Statement
10th Dec 20187:00 amRNSContract Renewals
31st Oct 20187:00 amRNSAppointment of Director
3rd Oct 201811:00 amRNSAppointment of Director
18th Sep 20187:00 amRNSHalf-year Report
14th Aug 20187:00 amRNSIngenta announces two new multi-year contracts
9th Aug 20187:00 amRNSDirectorate Update
26th Jun 20185:58 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSIngenta announces new VAR partnership with ATC
24th May 201812:09 pmRNSAGM Statement & Results of AGM
27th Apr 20187:00 amRNSDividend Declaration, Posting of AR&A & AGM Notice
29th Mar 20187:00 amRNSFinal Results
27th Mar 20183:18 pmRNSCapital Reduction
22nd Feb 20187:00 amRNSSainsbury's sign 3-year agreement with Ingenta
19th Feb 201811:36 amRNSResult of General Meeting
26th Jan 20187:01 amRNSNotice of GM and Proposed Capital Reduction
26th Jan 20187:00 amRNSTrading Update
20th Nov 20177:00 amRNSYewno Appoints PCG to Drive Sales
21st Sep 20173:10 pmRNSGrant of Options
19th Sep 201710:16 amRNSDirector/PDMR Shareholding
18th Sep 201712:21 pmRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSInterim Results
15th Aug 20177:00 amRNSContract Win
15th Aug 20177:00 amRNSPre Close Trading Update
19th Jun 201711:41 amRNSDirectorate Disclosure
31st May 20173:50 pmRNSResult of AGM
18th May 20172:36 pmRNSPosting of Annual Report and Accounts
7th Apr 20179:28 amRNSDividend Declaration and notice of AGM
3rd Apr 20177:00 amRNSFinal Results
16th Jan 20177:00 amRNSTrading Update
30th Dec 20162:00 pmRNSDirector/PDMR Shareholding
30th Dec 20161:54 pmRNSDirector/PDMR Shareholding
6th Dec 20165:46 pmRNSDirector/PDMR Shareholding
28th Nov 20167:00 amRNSSenior Management Appointments
22nd Nov 20169:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.